Gao cited for nanomedical oncology research

By Debbie Bolles / August 2011

Dr. Jinming Gao, professor of pharmacology in the Harold C. Simmons Comprehensive Cancer Center, recently received the Distinguished Scientist Award and Best Paper Award for 2010 from the Society for Experimental Biology and Medicine. The awards are based on Dr. Gao’s research and development of new nanomedicine platforms for cancer detection and treatment.

“The society has recently launched a series of initiatives to foster interdisciplinary and translational sciences,” Dr. Gao said. “I am glad that I contributed to this cause.”

Jinming Gao, PhD

The Society for Experimental Biology and Medicine (SEBM) established the Distinguished Scientist Award to recognize biomedical scientists whose seminal research accomplishments have established them as leaders in biomedicine. Dr. Gao is one of nine researchers nationwide to receive this award, which also is based on contributions to the society.

“These fundamental contributions have advanced the field of cancer detection and treatment, providing oncologists with new weapons to battle the most devastating cancers,” said Dr. Robert T. Mallet, chairman of the SEBM Distinguished Scientist Award Selection Committee, on Dr. Gao’s research developing minute lipid particles as novel, nanotechnology-based drug delivery systems.

Dr. Gao and his research team also received a Best Paper for 2010 Award, one of three such awards issued by the society. His specific award, the Alan MacDiarmid Award in the Interdisciplinary Research Category, related to the article “In vivo angiogenesis imaging of solid tumors by αvβ3-targeted, dual-modality micellar nanoprobes” that was published in the August 2010 issue of Experimental Biology and Medicine, the society’s journal.

Use of such nanoprobes may lead to earlier detection of tumors and noninvasive post-therapy assessment of anti-angiogenic drugs.

Dr. Gao was the corresponding author of the article; first author was Chase W. Kessinger, a student research assistant in the cancer biology track. Other UT Southwestern researchers who contributed to the study were Dr. Chalermchai Khemtong, a postdoctoral researcher in the Harold C. Simmons Cancer Center; Dr. Osamu Togao, a postdoctoral researcher in the Advanced Imaging Research Center (AIRC); Dr. Masaya Takahashi, associate professor in the AIRC and radiology; and Dr. Baran Sumer, assistant professor of otolaryngology-head and neck surgery. 

Share: